Delivery Order SPE2DU25D9809-SPE2DU26F0V87
- Not listed
- The Defense Logistics Agency issued a $2,494.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, IL. DMS...
- The Defense Logistics Agency issued a $4,764.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical...
- The Defense Logistics Agency issued a $1,592.34 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 7, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency program structured as a single-award indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription...
- The Defense Logistics Agency issued a $65,779.20 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on February 5, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, with a ceiling value of $1,931.83 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products, including branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. The order ceiling is $1,017.13 and carries a firm fixed price. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing DLA to issue delivery orders for pharmaceutical products including branded...
- The Defense Logistics Agency issued a $17,688.64 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products supporting Department of Defense medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 4, 2026, with a ceiling value of $85,700.12 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, with a ceiling value of $21,573 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 5, 2026, with a ceiling value of $3,691.14 for pharmaceutical products. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award Indefinite Delivery Contract with a $499,999,999 ceiling that authorizes DLA to procure branded and generic prescription...
- SPE2DU25D9809Indefinite Delivery Contract
- SPE2DU25D9809-SPE2DU26F0V87Delivery Order
The Defense Logistics Agency issued a $1,388.44 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on February 6, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract for pharmaceutical supply to federal agencies. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC under this program with a $499.999 billion ceiling and ultimate completion date of December 31, 2036. Place of performance is Park Ridge, Illinois. The delivery order has an ultimate completion date of February 9, 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/5/26 |